• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

传染病研究所具有影响力的研究和艾滋病毒护理的纵向患者队列。

Longitudinal patients' cohorts for impactful research and HIV care at the Infectious Diseases Institute.

机构信息

Infectious Diseases Institute, College of Health Science, Makerere University.

College of Health Science, Makerere University.

出版信息

Afr Health Sci. 2022 Aug;22(Spec Issue):11-21. doi: 10.4314/ahs.v22i2.4S.

DOI:10.4314/ahs.v22i2.4S
PMID:36321114
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9590324/
Abstract

INTRODUCTION

Observational studies provide important evidence supporting the feasibility and effectiveness of health interventions. The 20-year-old Infectious Diseases Institute (IDI) established to respond to infectious diseases, specifically HIV/AIDS, invested in the set-up of longitudinal cohorts. In this paper we discuss the results of these cohorts and their impact on the response to the HIV pandemic in Uganda.

METHODS

IDI invested in experienced system developers, clinic and laboratory capacity to create the infrastructure to host longitudinal cohorts. Several cohorts were created, including patients initiated and followed up on ART, specialized cohorts (e.g. TB co-infection) and long-term cohorts with patients on ART for over 10 years and aged 60 and above. These cohorts function as platforms for sub-studies, attracting collaborators and students.

RESULTS

Data from the IDI cohorts contributed evidence to ART programs on when to start, which drugs to use, how to best monitor and which models of care to implement. Sub-studies contributed to management of opportunistic infections, understanding immunological response and the emerging complications of non-communicable diseases.

CONCLUSION

Cohorts provide a platform for clinical care, training, and research to inform strategic responses and put Makerere University at the center of the response to the HIV pandemic in the region.

摘要

简介

观察性研究为卫生干预措施的可行性和有效性提供了重要证据。为应对传染病,特别是艾滋病毒/艾滋病而成立的 20 岁的传染病研究所(IDI)投资建立了纵向队列。本文讨论了这些队列的结果及其对乌干达应对艾滋病毒大流行的影响。

方法

IDI 投资于经验丰富的系统开发人员、诊所和实验室能力,以建立容纳纵向队列的基础设施。创建了几个队列,包括开始并接受抗逆转录病毒疗法(ART)治疗和随访的患者、专门队列(例如结核分枝杆菌合并感染)以及接受 ART 治疗 10 年以上且年龄在 60 岁及以上的长期队列。这些队列是子研究的平台,吸引了合作者和学生。

结果

IDI 队列的数据为 ART 项目提供了关于何时开始、使用哪些药物、如何最佳监测以及实施哪种护理模式的证据。子研究有助于管理机会性感染、了解免疫反应以及非传染性疾病的新出现并发症。

结论

队列为临床护理、培训和研究提供了一个平台,为战略应对提供信息,并使马凯雷雷大学成为该地区应对艾滋病毒大流行的中心。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b292/9590324/7c6d723591f1/AFHS22S1-0011Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b292/9590324/7c6d723591f1/AFHS22S1-0011Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b292/9590324/7c6d723591f1/AFHS22S1-0011Fig1.jpg

相似文献

1
Longitudinal patients' cohorts for impactful research and HIV care at the Infectious Diseases Institute.传染病研究所具有影响力的研究和艾滋病毒护理的纵向患者队列。
Afr Health Sci. 2022 Aug;22(Spec Issue):11-21. doi: 10.4314/ahs.v22i2.4S.
2
The Infectious Diseases Institute at Makerere University, Kampala, Uganda.乌干达坎帕拉市马凯雷雷大学传染病研究所。
Infect Dis Clin North Am. 2011 Jun;25(2):369-83. doi: 10.1016/j.idc.2011.02.007.
3
Human immunodeficiency virus and AIDS in Uganda.乌干达的人类免疫缺陷病毒与艾滋病
East Afr Med J. 1996 Jan;73(1):20-6.
4
Adherence to standards of quality HIV/AIDS care and antiretroviral therapy in the West Nile Region of Uganda.乌干达西尼罗河地区对优质艾滋病毒/艾滋病护理和抗逆转录病毒疗法标准的遵守情况。
BMC Health Serv Res. 2014 Nov 18;14:521. doi: 10.1186/s12913-014-0521-5.
5
Antiretroviral treatment Long-Term (ALT) cohort: a prospective cohort of 10 years of ART-experienced patients in Uganda.抗逆转录病毒长期治疗(ALT)队列:乌干达一组接受抗逆转录病毒治疗达10年的有经验患者的前瞻性队列。
BMJ Open. 2018 Feb 21;8(2):e015490. doi: 10.1136/bmjopen-2016-015490.
6
Collaborative research to respond to the HIV epidemic: a case of Uganda (Makerere University)-Case Western Reserve University Research Collaboration 1988-2021.合作研究应对艾滋病疫情:乌干达(马凯雷雷大学)-凯斯西储大学研究合作 1988-2021 年案例。
Afr Health Sci. 2022 Aug;22(Spec Issue):51-56. doi: 10.4314/ahs.v22i2.8S.
7
Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda.通过在乌干达实施混合护理模式来应对耐多药结核病挑战。
PLoS One. 2020 Dec 29;15(12):e0244451. doi: 10.1371/journal.pone.0244451. eCollection 2020.
8
Using a clinic based creativity initiative to reduce HIV related stigma at the Infectious Diseases Institute, Mulago National Referral Hospital, Uganda.在乌干达穆拉戈国家转诊医院传染病研究所,利用一项基于诊所的创意倡议来减少与艾滋病相关的耻辱感。
Afr Health Sci. 2012 Jun;12(2):231-9. doi: 10.4314/ahs.v12i2.24.
9
Makerere's contribution to the development of a high impact HIV research population-based cohort in the Rakai Region, Uganda.马凯雷雷大学在乌干达拉凯地区建立一个有影响力的 HIV 人群队列研究中的贡献。
Afr Health Sci. 2022 Aug;22(Spec Issue):42-50. doi: 10.4314/ahs.v22i2.7S.
10
Temporal trends in death causes in adults attending an urban HIV clinic in Uganda: a retrospective chart review.乌干达一家城市艾滋病诊所成年就诊者死亡原因的时间趋势:一项回顾性图表审查
BMJ Open. 2016 Jan 6;6(1):e008718. doi: 10.1136/bmjopen-2015-008718.

引用本文的文献

1
Barriers and facilitators of adherence to long-term antiretroviral treatment in Kampala, Uganda.乌干达坎帕拉长期抗逆转录病毒治疗依从性的障碍与促进因素
PLOS Glob Public Health. 2025 Mar 13;5(3):e0004121. doi: 10.1371/journal.pgph.0004121. eCollection 2025.
2
A programmatic assessment of dolutegravir adverse events and discontinuations in Uganda.乌干达多替拉韦不良事件及停药情况的方案评估。
HIV Med. 2025 Apr;26(4):592-605. doi: 10.1111/hiv.13761. Epub 2025 Jan 24.
3
Experiences and lessons learned from a global research administration capacity building project to support and expand HIV/AIDS research in southwestern Uganda.

本文引用的文献

1
Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries.全球经缺失病毒载量测量校正的抗逆转录病毒治疗儿童和青少年及成人病毒抑制估计数:31 个国家的多区域回顾性队列研究。
Lancet HIV. 2021 Dec;8(12):e766-e775. doi: 10.1016/S2352-3018(21)00265-4.
2
Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity : An Observational Study.在最初对致畸性的担忧之后,影响中低收入国家处于生育年龄的 HIV 感染女性使用多替拉韦的差异:一项观察性研究。
Ann Intern Med. 2022 Jan;175(1):84-94. doi: 10.7326/M21-3037. Epub 2021 Nov 30.
3
从一个全球研究管理能力建设项目中获得的经验和教训,该项目旨在支持并扩大乌干达西南部的艾滋病毒/艾滋病研究。
Discov Health Syst. 2024;3(1). doi: 10.1007/s44250-024-00118-1. Epub 2024 Jul 16.
4
Chronic immune activation and accelerated immune aging among HIV-infected adults receiving suppressive antiretroviral therapy for at least 12 years in an African cohort.在一个非洲队列中,接受至少12年抑制性抗逆转录病毒治疗的HIV感染成年人中存在慢性免疫激活和加速免疫衰老的情况。
Heliyon. 2024 May 24;10(11):e31910. doi: 10.1016/j.heliyon.2024.e31910. eCollection 2024 Jun 15.
5
A century of Makerere and 22 years of academic publishing: African Health Sciences into a new gear.马凯雷雷大学百年历程与22年学术出版:《非洲健康科学》迈向新征程。
Afr Health Sci. 2022 Aug;22(Spec Issue):i-ii. doi: 10.4314/ahs.v22i2.1S.
Innate lymphoid cell dysfunction during long-term suppressive antiretroviral therapy in an African cohort.在非洲队列中,长期抑制性抗逆转录病毒治疗期间固有淋巴细胞功能障碍。
BMC Immunol. 2021 Aug 26;22(1):59. doi: 10.1186/s12865-021-00450-8.
4
Low bone mass in people living with HIV on long-term anti-retroviral therapy: A single center study in Uganda.长期抗逆转录病毒治疗的艾滋病毒感染者低骨量:乌干达的一项单中心研究。
PLoS One. 2021 Feb 5;16(2):e0246389. doi: 10.1371/journal.pone.0246389. eCollection 2021.
5
Limitations of Randomized Clinical Trials.随机临床试验的局限性。
Am J Cardiol. 2020 Aug 15;129:109-115. doi: 10.1016/j.amjcard.2020.05.011. Epub 2020 May 16.
6
Calcaneal Quantitative Ultrasonography and Urinary Retinol-Binding Protein in Antiretroviral-Treated Patients With Human Immunodeficiency Virus in Uganda: A Pilot Study.在乌干达接受抗逆转录病毒治疗的人类免疫缺陷病毒感染者的跟骨定量超声和尿视黄醇结合蛋白:一项初步研究。
J Infect Dis. 2020 Jun 29;222(2):263-272. doi: 10.1093/infdis/jiaa088.
7
Dolutegravir-associated hyperglycaemia in patients with HIV.HIV患者中与多替拉韦相关的高血糖症
Lancet HIV. 2020 Jul;7(7):e461-e462. doi: 10.1016/S2352-3018(20)30042-4. Epub 2020 Feb 24.
8
Reasons for first line ART modification over the years during the ART scale up in Uganda.乌干达在扩大抗逆转录病毒疗法(ART)规模的这些年里,一线抗逆转录病毒疗法(ART)改变的原因。
AIDS Res Ther. 2019 Oct 9;16(1):31. doi: 10.1186/s12981-019-0246-y.
9
Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey.纳入癌症老年患者参与临床试验:SAGE 前瞻性多中心队列研究。
Oncologist. 2019 Dec;24(12):e1351-e1359. doi: 10.1634/theoncologist.2019-0166. Epub 2019 Jul 19.
10
Monocyte Dysfunction, Activation, and Inflammation After Long-Term Antiretroviral Therapy in an African Cohort.长期抗逆转录病毒治疗后,非洲队列中单核细胞功能障碍、激活和炎症。
J Infect Dis. 2019 Sep 26;220(9):1414-1419. doi: 10.1093/infdis/jiz320.